Australia Stock Exchange release from EXOPHARM LIMITED : Positive PLEXOVAL II Phase 1 Clinical Trial Results
05/04/2021 23:21
Australia Stock Exchange release from EXOPHARM LIMITED EX1.AX : Positive PLEXOVAL II Phase 1 Clinical Trial Results
Recent news on Entropy Neurodynamics
See all newsBrief: Entropy Neurodynamics Seeks Trading Halt
Brief: Entropy Neurodynamics Says Strategic Agreement Signed With CDMO Biocina
Brief: Entropy Neurodynamics Secures HREC Approval For Phase 1B/2A 8-Indication Basket Study Of TRP-8803
Brief: Entropy Neurodynamics Requests Trading Halt
Brief: Entropy Neurodynamics Seeks Trading Halt